Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan H Baik

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Circulation Research|May 3, 2021
Preclinical Models of Cancer Therapy-Associated Cardiovascular Toxicity: A Scientific Statement From the American Heart AssociationAarti Asnani, Javid J Moslehi, Bishow B Adhikari, et al.
Molecular Cell|March 9, 2023
Oxygen toxicity causes cyclic damage by destabilizing specific Fe-S cluster-containing protein complexesAlan H Baik, Augustinus G Haribowo, Xuewen Chen, et al.
Circulation|June 28, 2023
Equity in Cardio-Oncology Care and Research: A Scientific Statement From the American Heart AssociationDaniel Addison, Mary Branch, Alan H Baik, et al.
European Heart Journal. Acute Cardiovascular Care|July 4, 2026
Hyperoxia reflects poor native cardiac function and demonstrates cardiac index-dependent associations with mortality in VA-ECMO patientsRyan K Ruaysungnoen, Anja Strehlow, Sylvie Baudart, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Genome-wide CRISPRi screen identifies basigin loss as protective in cardiac hypoxiaWill R Flanigan, Ayush D Midha, Skyler Y Blume, et al.
Cell Metabolism|February 20, 2026
Red blood cells serve as a primary glucose sink to improve glucose tolerance at altitudeYolanda Martí-Mateos, Zohreh Safari, Shaun Bevers, et al.
Science Advances|December 8, 2023
In vivo protein turnover rates in varying oxygen tensions nominate MYBBP1A as a mediator of the hyperoxia responseXuewen Chen, Augustinus G Haribowo, Alan H Baik, et al.
Cell|February 27, 2016
EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic ProtectionBenjamin A Olenchock, Javid Moslehi, Alan H Baik, et al.
JAMA Cardiology|July 7, 2021
Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative ReviewLorenz H Lehmann, Jennifer Cautela, Nicolas Palaskas, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Systemic hypoxia suppresses solid tumor growthAyush D Midha, Brandon T L Chew, Benedict M H Choi, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Circulation Research|May 3, 2021
Preclinical Models of Cancer Therapy-Associated Cardiovascular Toxicity: A Scientific Statement From the American Heart AssociationAarti Asnani, Javid J Moslehi, Bishow B Adhikari, et al.
Molecular Cell|March 9, 2023
Oxygen toxicity causes cyclic damage by destabilizing specific Fe-S cluster-containing protein complexesAlan H Baik, Augustinus G Haribowo, Xuewen Chen, et al.
Circulation|June 28, 2023
Equity in Cardio-Oncology Care and Research: A Scientific Statement From the American Heart AssociationDaniel Addison, Mary Branch, Alan H Baik, et al.
European Heart Journal. Acute Cardiovascular Care|July 4, 2026
Hyperoxia reflects poor native cardiac function and demonstrates cardiac index-dependent associations with mortality in VA-ECMO patientsRyan K Ruaysungnoen, Anja Strehlow, Sylvie Baudart, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Genome-wide CRISPRi screen identifies basigin loss as protective in cardiac hypoxiaWill R Flanigan, Ayush D Midha, Skyler Y Blume, et al.
Cell Metabolism|February 20, 2026
Red blood cells serve as a primary glucose sink to improve glucose tolerance at altitudeYolanda Martí-Mateos, Zohreh Safari, Shaun Bevers, et al.
Science Advances|December 8, 2023
In vivo protein turnover rates in varying oxygen tensions nominate MYBBP1A as a mediator of the hyperoxia responseXuewen Chen, Augustinus G Haribowo, Alan H Baik, et al.
Cell|February 27, 2016
EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic ProtectionBenjamin A Olenchock, Javid Moslehi, Alan H Baik, et al.
JAMA Cardiology|July 7, 2021
Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative ReviewLorenz H Lehmann, Jennifer Cautela, Nicolas Palaskas, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Systemic hypoxia suppresses solid tumor growthAyush D Midha, Brandon T L Chew, Benedict M H Choi, et al.
Pageof 3